Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
LIC MF Healthcare Fund(G)-Direct Plan
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.9.8676466238.3031
Domestic EquitiesPiramal Pharma Ltd.7.26022273166.1091
Domestic EquitiesArtemis Medicare Services Ltd.6.66031704485.6043
Domestic EquitiesTorrent Pharmaceuticals Ltd.5.3522135484.5036
Domestic EquitiesSyngene International Ltd.4.5423406263.8221
Domestic EquitiesGlenmark Pharmaceuticals Ltd.4.4716246143.7626
Domestic EquitiesMankind Pharma Ltd.4.3210141963.6359
Domestic EquitiesNeuland Laboratories Ltd.4.235621333.5641
Domestic EquitiesCipla Ltd.4.1861229643.5224
Domestic EquitiesSuven Pharmaceuticals Ltd.4.0784262813.4318
Domestic EquitiesDivi's Laboratories Ltd.4.070655493.4252
Domestic EquitiesJB Chemicals & Pharmaceuticals Ltd.3.9964193793.3628
Domestic EquitiesAbbott India Ltd.3.937111953.3129
Domestic EquitiesIPCA Laboratories Ltd.3.9303214403.3072
Domestic EquitiesAlkem Laboratories Ltd.3.362250142.8291
Domestic EquitiesLaurus Labs Ltd.3.3443496182.8141
Domestic EquitiesGlobal Health Ltd.3.2558254812.7396
Domestic EquitiesNavin Fluorine International Ltd.3.041672962.5594
Domestic EquitiesZydus Lifesciences Ltd.2.9894260412.5154
Domestic EquitiesApollo Hospitals Enterprise Ltd.2.913535902.4516
Domestic EquitiesMetropolis Healthcare Ltd.2.155784701.8139
Domestic EquitiesDr. Reddy's Laboratories Ltd.2.1197148351.7836
Domestic EquitiesYatharth Hospital&Trauma Care Serv Ltd.1.7294244721.4552
Total 95.8212 80.6290
Cash & Cash Equivalents and Net AssetsTreps4.3960 3.6990
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)-0.2171 -0.1827
Total 4.1788 3.5163
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.